StacksVerified U.S. regulatory reference

38 CFR §4.100

Verified against eCFR.gov as of June 20, 2026View official text on eCFR.gov ↗
  1. (a)Whether or not cardiac hypertrophy or dilatation (documented by electrocardiogram, echocardiogram, or X-ray) is present and whether or not there is a need for continuous medication must be ascertained in all cases.
  2. (b)Even if the requirement for a 10% (based on the need for continuous medication) or 30% (based on the presence of cardiac hypertrophy or dilatation) evaluation is met, METs testing is required in all cases except:
    1. (1)When there is a medical contraindication.
    2. (2)When a 100% evaluation can be assigned on another basis.